Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.

Ro(SS-A) positive female Sjögren's syndrome (SS) lupus erythematosus (LE) overlap patients are a clinically and serologically homogeneous group generally demonstrating prominent subacute cutaneous lupus erythematosus (SCLE) lesions, cutaneous vasculitis, peripheral and central nervous system disease, pulmonary disease, and a low frequency of glomerulonephritis. They commonly demonstrate rheumatoid factor, hypergammaglobulinemia, antinuclear and Ro(SS-A) La(SS-B) antibody activity. This study indicates that these patients are also immunogenetically similar, sharing a statistically significant increased frequency of HLA-B8, DR3, DRW6, DQ2, and DRw52. Sixty-three percent of these SS/LE patients possess the extended haplotype (P-value 6.0 X 10(-3); RR 9.5) HLA-B8, DR3, DQ2, DRw52. One hundred percent of this SS/LE cohort was DR3 or DRw6 (P-value less than or equal to 5.0 X 10(-3); relative risk 19.1). Fifty percent of these patients were HLA DR3/DRw6 heterozygotes (P-value 1.5 X 10(-6); relative risk 31.2). Thus, HLA-DR3 and DRw6 Ro(SS-A) positive SS/LE patients may possess a similar, if not unique, DR region DNA nucleotide sequence involved in disease susceptibility or immune regulation.

[1]  W. Aberer,et al.  Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[2]  B. Mach,et al.  Polymorphism of human Ia antigens: gene conversion between two DR β loci results in a new HLA-D/DR specificity , 1986, Nature.

[3]  F. Arnett,et al.  Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. , 1986, Science.

[4]  F. Arnett,et al.  Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. , 1986, Arthritis and rheumatism.

[5]  R. E. Boyd,et al.  Systemic Lupus Erythematosus: A Review of Clinico‐Laboratory Features and Immunogenetic Markers in 150 Patients with Emphasis on Demographic Subsets , 1985, Medicine.

[6]  M. Hochberg,et al.  Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. , 1984, Arthritis and rheumatism.

[7]  F. Arnett,et al.  Neonatal Lupus Erythematosus: A CLINICAL, SEROLOGICAL AND IMMUNOGENETIC STUDY WITH REVIEW OF THE LITERATURE , 1984, Medicine.

[8]  G. Smith,et al.  Systemic lupus erythematosus in the elderly: clinical and serological characteristics. , 1984, The Journal of rheumatology.

[9]  F. Arnett,et al.  Immunogenetics of the Neonatal Lupus Syndrome , 1983 .

[10]  P. Stastny,et al.  Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. , 1982, Annals of internal medicine.

[11]  F. Arnett,et al.  Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[12]  D. Bell,et al.  Serologic subsets in systemic lupus erythematosus , 1980 .

[13]  R. Winchester,et al.  Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus , 1978, The Journal of experimental medicine.

[14]  A. Steinberg,et al.  B-lymphocyte alloantigens associated with systemic lupus erythematosus. , 1978, The New England journal of medicine.

[15]  J. Harley,et al.  The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. , 1988, Archives of dermatology.

[16]  P. Stastny,et al.  Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus. , 1981, The Journal of clinical investigation.